» Articles » PMID: 35063957

Prevalence of Depression and Anxiety Symptoms and Their Determinant Factors Among Patients with Cancer in Southern Ethiopia: a Cross-sectional Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2022 Jan 22
PMID 35063957
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The study was aimed to assess the prevalence of depression and anxiety symptoms and their determinant factors among patients with cancer attending follow-up at Hawassa University Comprehensive Specialized Hospital cancer treatment centre, Ethiopia.

Design: Institution-based cross-sectional study design was implemented.

Setting: Patients with cancer at Hawassa University Comprehensive Specialized Hospital cancer treatment centre from October 2019 to December 2019.

Participants: Randomly selected 415 patients with cancer who had follow-up at cancer treatment centre.

Main Outcome Measures: Anxiety and depression symptoms were assessed using Hospital Anxiety and Depression Scale.

Result: The prevalence rates of depression and anxiety symptoms were found to be 244 (58.8%) and 249 (60.0%), respectively. Older age (>50 years) (AOR (adjusted OR)=2.24, 95% CI=1.14 to 4.40), being unemployed (AOR=1.96, 95% CI=1.08 to 3.56), advanced stage of cancer such as stage III (AOR=5.37, 95% CI=1.34 to 21.45) and stage IV (AOR=4.55, 95% CI=1.12 to 18.44), comorbid psychotic symptoms (AOR=1.67, 95% CI=1.07 to 2.61) and eating problem in the past 2 weeks (AOR=6.16, 95% CI=1.98 to 19.11) were independent factors significantly associated with depressive symptoms. In addition, cancer stage such as stage II (AOR=3.92, 95% CI=1.07 to 14.36) and stage IV (AOR=5.04, 95% CI=1.44 to 17.59) and comorbid psychotic symptoms (AOR=1.73, 95% CI=1.12 to 2.66) were significantly associated with anxiety symptoms.

Conclusion: Depression and anxiety symptoms among patients with cancer were considerably high. Age, occupation, cancer stage, comorbid psychotic symptoms and eating problem were determinant factors of depressive symptoms among patients with cancer. Moreover, cancer stage and comorbid psychosis were determinants of anxiety symptoms. Healthcare professionals working in the oncology unity need to conduct routine screening and treatment of depression and anxiety symptoms for patients with cancer.

Citing Articles

Prevalence and determinants of depression and its association with social support among cancer patients: implications for enhancing oncology care.

Alkubati S, Halboup A, Zoromba M, El-Gazar H, Pasay-An E, Salameh B BMC Psychol. 2025; 13(1):232.

PMID: 40069840 PMC: 11900610. DOI: 10.1186/s40359-025-02584-5.


Prevalence and associated risk factors of suicidal behaviors among cancer patients in a tertiary care hospital in Bangladesh.

Emi M, Imran S, Adib A, Al Mamun F, Mamun M, Islam F Sci Rep. 2025; 15(1):7055.

PMID: 40016336 PMC: 11868623. DOI: 10.1038/s41598-024-84731-3.


Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses.

Getie A, Ayalneh M, Bimerew M BMC Psychiatry. 2025; 25(1):156.

PMID: 39972435 PMC: 11841195. DOI: 10.1186/s12888-025-06599-5.


Depression, anxiety and associated factors among cancer patients in Africa; a systematic review and meta-analysis study.

Nakie G, Melkam M, Takelle G, Fentahun S, Rtbey G, Andualem F BMC Psychiatry. 2024; 24(1):939.

PMID: 39716105 PMC: 11668085. DOI: 10.1186/s12888-024-06389-5.


Breast Cancer and Risk of Depression: A Comparative Cross-Sectional Study Among Women With and Without Breast Cancer in Addis Ababa, Ethiopia.

Gebremariam A, Addissie A, Dereje N, Assefa M, Jemal A JCO Glob Oncol. 2024; 10:e2400235.

PMID: 39388658 PMC: 11487996. DOI: 10.1200/GO.24.00235.


References
1.
Nikbakhsh N, Moudi S, Abbasian S, Khafri S . Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med. 2014; 5(3):167-70. PMC: 4143739. View

2.
Boen H, Dalgard O, Bjertness E . The importance of social support in the associations between psychological distress and somatic health problems and socio-economic factors among older adults living at home: a cross sectional study. BMC Geriatr. 2012; 12:27. PMC: 3464708. DOI: 10.1186/1471-2318-12-27. View

3.
Block S . Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med. 2000; 132(3):209-18. DOI: 10.7326/0003-4819-132-3-200002010-00007. View

4.
Zhu J, Fang F, Sjolander A, Fall K, Adami H, Valdimarsdottir U . First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol. 2017; 28(8):1964-1969. DOI: 10.1093/annonc/mdx265. View

5.
Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A . Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000; 356(9238):1326-7. DOI: 10.1016/S0140-6736(00)02821-X. View